Brian J Park, MD | |
2000 Washington St, Green Building -- Suite 668, Newton, MA 02462-1650 | |
(617) 630-1699 | |
Not Available |
Full Name | Brian J Park |
---|---|
Gender | Male |
Speciality | Otolaryngology |
Experience | 22 Years |
Location | 2000 Washington St, Newton, Massachusetts |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1396969598 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Y00000X | Otolaryngology | 239954 (Massachusetts) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Newton-wellesley Hospital | Newton, MA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Massachusetts Eye And Ear Associates, Inc | 4486540275 | 337 |
News Archive
A major clinical trial finds that a combination of two common medications - tolterodine (Detrol LA) and tamsulosin (Flomax) - works better than either drug alone for men struggling with lower urinary tract symptoms, including tough-to-treat overactive bladder (OAB).
Cryptosporidium parvum, an insidious, one-celled, waterborne parasite that lodges in the intestines of infected people and animals and for which there is currently no effective treatment, is missing key structures normally found in similar parasites, say researchers supported by the National Institute of Allergy and Infectious Diseases (NIAID), one of the National Institutes of Health. The results of their genome sequencing project, could help scientists home in on new drug targets that may lead to therapies for the disease.
The Arthritis Foundation applauds the U.S. House of Representatives for passing the Arthritis Prevention, Control and Cure Act (H.R. 1210/S.984), the first comprehensive, bipartisan arthritis legislation in more than 30 years.
Neogen Corporation has developed a quick and easy new test for aflatoxin, a toxin considered by many to be the most potent, naturally-occurring carcinogen. The toxin is a by-product of mold growth in a wide range of commodities, including corn.
› Verified 4 days ago
Entity Name | Newton-wellesley Medical Group, Inc. |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1538191218 PECOS PAC ID: 0244133494 Enrollment ID: O20040127001012 |
News Archive
A major clinical trial finds that a combination of two common medications - tolterodine (Detrol LA) and tamsulosin (Flomax) - works better than either drug alone for men struggling with lower urinary tract symptoms, including tough-to-treat overactive bladder (OAB).
Cryptosporidium parvum, an insidious, one-celled, waterborne parasite that lodges in the intestines of infected people and animals and for which there is currently no effective treatment, is missing key structures normally found in similar parasites, say researchers supported by the National Institute of Allergy and Infectious Diseases (NIAID), one of the National Institutes of Health. The results of their genome sequencing project, could help scientists home in on new drug targets that may lead to therapies for the disease.
The Arthritis Foundation applauds the U.S. House of Representatives for passing the Arthritis Prevention, Control and Cure Act (H.R. 1210/S.984), the first comprehensive, bipartisan arthritis legislation in more than 30 years.
Neogen Corporation has developed a quick and easy new test for aflatoxin, a toxin considered by many to be the most potent, naturally-occurring carcinogen. The toxin is a by-product of mold growth in a wide range of commodities, including corn.
› Verified 4 days ago
Entity Name | Massachusetts Eye And Ear Associates, Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1932574332 PECOS PAC ID: 4486540275 Enrollment ID: O20040227000123 |
News Archive
A major clinical trial finds that a combination of two common medications - tolterodine (Detrol LA) and tamsulosin (Flomax) - works better than either drug alone for men struggling with lower urinary tract symptoms, including tough-to-treat overactive bladder (OAB).
Cryptosporidium parvum, an insidious, one-celled, waterborne parasite that lodges in the intestines of infected people and animals and for which there is currently no effective treatment, is missing key structures normally found in similar parasites, say researchers supported by the National Institute of Allergy and Infectious Diseases (NIAID), one of the National Institutes of Health. The results of their genome sequencing project, could help scientists home in on new drug targets that may lead to therapies for the disease.
The Arthritis Foundation applauds the U.S. House of Representatives for passing the Arthritis Prevention, Control and Cure Act (H.R. 1210/S.984), the first comprehensive, bipartisan arthritis legislation in more than 30 years.
Neogen Corporation has developed a quick and easy new test for aflatoxin, a toxin considered by many to be the most potent, naturally-occurring carcinogen. The toxin is a by-product of mold growth in a wide range of commodities, including corn.
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
Brian J Park, MD 2000 Washington St, Green Building -- Suite 668, Newton, MA 02462-1650 Ph: (617) 630-1699 | Brian J Park, MD 2000 Washington St, Green Building -- Suite 668, Newton, MA 02462-1650 Ph: (617) 630-1699 |
News Archive
A major clinical trial finds that a combination of two common medications - tolterodine (Detrol LA) and tamsulosin (Flomax) - works better than either drug alone for men struggling with lower urinary tract symptoms, including tough-to-treat overactive bladder (OAB).
Cryptosporidium parvum, an insidious, one-celled, waterborne parasite that lodges in the intestines of infected people and animals and for which there is currently no effective treatment, is missing key structures normally found in similar parasites, say researchers supported by the National Institute of Allergy and Infectious Diseases (NIAID), one of the National Institutes of Health. The results of their genome sequencing project, could help scientists home in on new drug targets that may lead to therapies for the disease.
The Arthritis Foundation applauds the U.S. House of Representatives for passing the Arthritis Prevention, Control and Cure Act (H.R. 1210/S.984), the first comprehensive, bipartisan arthritis legislation in more than 30 years.
Neogen Corporation has developed a quick and easy new test for aflatoxin, a toxin considered by many to be the most potent, naturally-occurring carcinogen. The toxin is a by-product of mold growth in a wide range of commodities, including corn.
› Verified 4 days ago
Xue Zhao, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 2000 Washington St Ste 668, Newton, MA 02462 Phone: 617-630-1699 | |
Jacob Ibrook Tower, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 335 Boylston St, Newton, MA 02459 Phone: 617-566-3223 | |
Dr. Kathryn A. Ryan, M.D. Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 2000 Washington St, Suite 668, Newton, MA 02462 Phone: 617-630-1699 | |
Dr. Mark F. Rounds, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 2000 Washington St, Suite 668, Newton, MA 02462 Phone: 617-630-1699 | |
Dr. Victor E. Calcaterra, M.D. Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 2000 Washington St, Suite 668, Newton, MA 02462 Phone: 617-630-1699 | |
Dr. Avner Aliphas, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 2000 Washington St, White Bldg, Suite 544, Newton, MA 02462 Phone: 617-910-0368 Fax: 888-806-8144 |